- Home
- IMRN vs NEPH Comparison
IMRN vs NEPH Comparison
Compare IMRN & NEPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMRN
- NEPH
- Stock Information
- Founded
- IMRN 1994
- NEPH 1997
- Country
- IMRN Australia
- NEPH United States
- Employees
- IMRN N/A
- NEPH N/A
- Industry
- IMRN Biotechnology: Pharmaceutical Preparations
- NEPH Medical/Dental Instruments
- Sector
- IMRN Health Care
- NEPH Health Care
- Exchange
- IMRN Nasdaq
- NEPH Nasdaq
- Market Cap
- IMRN 15.0M
- NEPH 16.8M
- IPO Year
- IMRN N/A
- NEPH 2004
- Fundamental
- Price
- IMRN $1.90
- NEPH $1.53
- Analyst Decision
- IMRN Strong Buy
- NEPH Buy
- Analyst Count
- IMRN 1
- NEPH 1
- Target Price
- IMRN $5.00
- NEPH $5.00
- AVG Volume (30 Days)
- IMRN 4.7K
- NEPH 19.2K
- Earning Date
- IMRN 03-03-2025
- NEPH 03-06-2025
- Dividend Yield
- IMRN N/A
- NEPH N/A
- EPS Growth
- IMRN N/A
- NEPH N/A
- EPS
- IMRN N/A
- NEPH N/A
- Revenue
- IMRN $3,271,194.00
- NEPH $13,546,000.00
- Revenue This Year
- IMRN N/A
- NEPH N/A
- Revenue Next Year
- IMRN N/A
- NEPH $9.13
- P/E Ratio
- IMRN N/A
- NEPH N/A
- Revenue Growth
- IMRN 171.67
- NEPH 0.03
- 52 Week Low
- IMRN $1.65
- NEPH $1.36
- 52 Week High
- IMRN $5.96
- NEPH $3.73
- Technical
- Relative Strength Index (RSI)
- IMRN 43.76
- NEPH 46.60
- Support Level
- IMRN $1.89
- NEPH $1.50
- Resistance Level
- IMRN $2.05
- NEPH $1.60
- Average True Range (ATR)
- IMRN 0.08
- NEPH 0.10
- MACD
- IMRN -0.02
- NEPH -0.01
- Stochastic Oscillator
- IMRN 3.85
- NEPH 22.24
About IMRN Immuron Limited
Immuron Ltd is a clinical-stage biopharmaceutical company focused on the development and commercialization of a novel class of immunomodulator polyclonal antibodies to treat liver diseases, infectious diseases and other immune-mediated diseases, such as colitis. The company's product, IMM-124E, is a proprietary immunomodulatory agent targeted at GI immune-mediated diseases including fatty liver diseases. The company functions in two segments namely, Research and Development and Hyperimmune products.
About NEPH Nephros Inc.
Nephros Inc is a commercial-stage company that develops and sells high-performance water solutions to the medical and commercial markets. In medical markets, it sells water filtration products and waterborne pathogen detection products. In commercial markets, the company manufactures and sells water filters that improve the taste and odor of water and reduce biofilm, bacteria, and scale build-up in downstream equipment. The company's subsidiary is engaged in the development of its second-generation hemodiafiltration system and other products focused on improving therapies for patients with renal disease.